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Summary The clearance of an intradermally-injected solution of 133Xenon in 0.9% saline has been used to
study the impairment and recovery of blood flow in mouse tail for 5 days following photodynamic therapy
(PDT) with 2mg TPPS i.v. per mouse and a range of doses of white light. Impairment of blood flow was
observed within 10min of light exposure. Blood flow increased between day 1 and day 5 at light doses
< 151 Jcm-2 and had returned to control levels by day 5 at light doses < 129Jcm-2. In mice treated with a
light dose that caused a 50% incidence of necrosis, there was no significant difference in the initial xenon
clearance half-time (measured at 10min and 1 day after PDT) between those mice which developed tail
necrosis and those which healed. However, the latter showed significantly greater improvement in vascular
function on days 2, 3 and 4. This suggests that the timing and extent of recovery of blood flow determined
the risk of necrosis in individual mice.
Photodynamic therapy (PDT) destroys tumour cells directly
as can be shown in vitro for monolayer (Dougherty, 1976)
and spheroid (Christensen et al., 1984) cultures. There is
increasing evidence however that in vivo the vasculature both
of tumours and normal tissues is promptly damaged by
PDT. Berenbaum et al. (1986) observed rapid (1 h)
breakdown of the blood-brain barrier as shown by increased
penetration of Evans blue dye and also found histological
changes in the vascular endothelial cells within 2h of
exposure of the cranium of mice to white light following i.v.
haematoporphyrin derivative. An electron microscopic study
(Zhou et al., 1985) found swelling and deformation in the
mitochondria and decreased density of the cytoplasmic
matrix in vascular endothelial cells in normal skin as early as
10min after PDT. Selman et al. (1985a) demonstrated a
significant decrease in blood flow to rat jejeunum 10min
after PDT using a radioactive microsphere technique and
this vascular deficiency was associated with a subsequent
degeneration of the dependent intestinal epithelium
(Chaudhuri et al., 1986). Selman et al. (1985b) also
investigated the relationship between blood flow at 24h and
tumour regression following PDT in a transplantable bladder
tumour in rats and found that both followed a similar dose
response curve. All these studies used haematoporphyrin
derivative as the photosensitizing drug. It is well established
therefore, that vascular injury occurs early after treatment by
PDT. Most studies have concentrated exclusively on these
early changes in structure and function. There is little
information on the probability and time scale of recovery of
blood flow following PDT or on how this relates to the
probability of necrosis in normal tissues. The extent and
time course of this recovery however may be important in
determining normal tissue tolerance following repeated
treatments with PDT.
The aims of this investigation were, therefore:
1. To study changes in vascular function for several days
following PDT using the clearance of a solution of
133Xenon injected intradermally.
2. To determine the relationships between the degree of
change of vascular function and the probability of
gross necrosis in skin using the mouse tail model
(Moore et al., 1986).
Materials and methods
Mice
Nine to 12-week old male mice of the pigmented inbred
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strain B6D2FI were used. The animals were housed in
subdued lighting conditions under a 12h dark (1800-0600h)
12h light regimen and were supplied with food and water ad
libitum.
Drug
Tetrasodium-meso-tetra(4-sulphophenyl)porphine dodeca-
hydrate, TPPS (Strem Chemicals, Newburyport, MA) was
dissolved in 0.9% saline. The drug was injected at 10.00h
when 2mg in an injection volume of 0.2ml was given as a
single i.v. bolus via the lateral tail vein. This corresponds to
a dose of 80mgkg-1 which is less than one third of the
LD10 dose. The animals were then housed in the dark for
24h prior to light treatment.
Light source
A 100W, 12V quartz tungsten halogen lamp (Xenophot
HLX; Wotan, London) was used with a KGI infra-red filter
(Schott, Mainz). This produced a continuous spectrum over
the range 300-1100nm with peak spectral irradiance at
-700nm. Optical lenses produced a circular beam of
uniform irradiance over a 2.5cm diameter (maximum fall-off
was 10%). The power density on the central axis at the
treatment distance was 75mWcm-2.
Light treatment
The animals were lightly restrained without anaesthesia in a
perspex container. The tube containing the tail was covered
with black tape apart from the central 2.5cm. The container
was then positioned with the central part of the tail across
the diameter of the light beam. Surface temperature during
illumination was measured with a thermocouple and was not
found to rise above 32.5°C.
Xenon clearance
The well-established xenon clearance technique is based on
the Kety principle (Kety, 1949), which assumes that a locally
deposited radioactive tracer is lost exponentially from the
site at which it is injected. If the logarithm of the remaining
activity is plotted against time a straight line is obtained, the
slope of which is a function of local blood flow. The half-
time (T1/2) for the xenon clearance is inversely related to
blood flow. Xenon is an inert gas which emits gamma
radiation of 80KeV with a physical half-life of 5.3 days. As
the solubility constant is low its biological half-life is much
shorter, with most being expelled in air on the first pass
through the lungs. Diffusion through cells and capillary
walls is rapid so its disappearance is a useful measure of
blood flow. It has been used previously to measure blood
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flow in mouse tails by de Ruiter and van Putten (1975)
following treatment with 300kV X-rays.
In the experiments reported here blood flow in the tails
was stimulated 15min before and during measurement by
raising ambient temperature to 37°C. The mice were
restrained in a perspex container and 5M1 of 133Xenon in
0.9% saline was injected intradermally into the distal end of
the treated area. The injection site was positioned under the
centre of a scintillation counter attached to a ratemeter and
the activity was recorded at 2min intervals for a minimum
of 10min. Results were analysed by a computer programme
to obtain the least-squares best fit for the exponential TI/2
for xenon clearance.
Experimental design:
1. Probability ofnecrosis vs. light dose There were 6 mice in
each experimental group and the experiments were repeated
once, the data being pooled. Groups of mice were treated
with doses of light in the range 90-202.5Jcm-2. Mice were
kept for 30 days and the proportion in which the tail was
lost distal to the proximal edge of the light beam was
recorded.
2. Time course of impairment and recovery of blood
flow There were 12 mice in each experimental group.
i) 24h after injection of TPPS the mice were treated with
either: 90JCcm-2, which was expected to be a tolerance dose
of light, i.e., to produce less than a 5% incidence of tail
necrosis; or 141 Jcm-2, a dose expected to produce tail
necrosis in - 50% of the mice. Values of the xenon clearance
T1/2 were then determined in different groups of animals at
10min and at 1, 2, 3, 4 or 5 days following light treatment.
A previous study had found that gross breakdown of tail
tissues only occurred on or after day 5 following treatment
by TPPS plus light (Moore, 1987).
ii) 24h after injection of TPPS, mice were treated with a
light dose in the range 45-225Jcm-2. The xenon clearance
was measured on day 1 and day 5 after light treatment for
each light dose, using different groups of mice for the two
intervals.
3. Relationship between functional vascular impairment and
necrosis in individual mice Animals treated with TPPS plus
141 Jcm-2 were individually tagged. Prior to injection with
TPPS the xenon clearance T1/2 was determined. This value
was also measured for each mouse following PDT as
described previously. The mean xenon clearance T1/2 values
prior to treatment and from 10min to 5 days post-treatment
could then be calculated for the animals which subsequently
underwent tail necrosis and for those whose tails healed.
4. Controls Three sets of controls were used. There were a
minimum of 24 animals in each control group. (i) Xenon
clearance was performed in untreated mice. (ii) Mice were
injected with 2mg TPPS and the xenon clearance was
measured 48h later. (iii) Mice were treated with 225Jcm-2
and the xenon clearance determined 24h later. All the
control animals were observed for 30 days.
Statistical analysis Data comparing incidence of necrosis
with light dose were analysed by a probit fitting programme
(Gilbert, 1969) to yield values for the ED50, i.e., the light
dose that caused a 50% incidence of necrosis in a group of
mice, and for 1/slope of the probit curve.
Values for xenon clearance T1/2 were normally distributed
in the control groups and were compared by one-way
analysis of variance. The results were positively skewed in
those groups treated with PDT using high light doses. This
data was therefore analysed by the Kruskal-Wallis test
which, if significant, was followed by multiple Mann-
Whitney U tests using a reduced significance level [0.05/n
where n is the number of multiple tests (e.g., for 8 groups n
is 28)] which allowed us to detect where the differences
between the groups were (Siegel, 1956).
Results
1) Probability of necrosis vs. light dose
As shown in Figure 1, the incidence of necrosis was
characterised by a threshold and subsequent steep increase in
incidence. Probit analysis yielded an ED50 dose of
137+ lOJcm-2 (error as 1 s.e.) and a 1/slope value of
34+15Jcm-2. Necrosis did not occur in any of the control
groups.
2) Xenon clearance TJ/2 data
i) Control groups The mean value for the xenon clearance
T1/2 at 24h for the animals treated with light only
(2.9+0.92min; error as 1 s.d.) and at 48h for the animals
injected with 2mg TPPS only (2.4+0.77min) were not
significantly different from the control group which had
received no treatment (2.6+0.57min). Groups treated with
both drug and light therefore were compared statistically
with the untreated controls.
ii) Time course of impairment and recovery of blood
flow Figure 2 shows the mean xenon clearance T1/2 for
different times between 10min and 5 days following PDT
with light doses of either 90Jcm-2 or 141 JCcm-2. The rise
in the T1/2 at 10min following PDT with 90Jcm-2 was
significant. The values peaked on day 2 and there was a
significant fall on day 3 although this value was still
significantly higher than the control. By days 4 and 5 the
values had fallen to levels which were not significantly
different than the control group (Kruskal-Wallis P<0.01).
The pattern obtained following PDT with a light dose of
141 Jcm-2 was similar but the results at all intervals were
now significantly greater than the control levels. The peak
level occurred on day 3 from which there was a significant
fall on days 4 and 5 (Kruskal-Wallis P<0.01).
Figure 3 shows T1/2 for xenon clearance on day 1 and
day 5 following a range of light doses. On day 1 the mean
T1/2 values increased with the light dose. Even at the lowest
light dose tested (45Jcm-2) the result was significantly
greater than the control and this was the case for all higher
light doses (Kruskal-Wallis P<0.01). By day 5 however, in
groups treated with <129Jcm-2 the T1/2 had returned to
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Figure 1 Probability of tail surviving vs. light dose in mice
illuminated 24h after 2mg TPPS i.v. Twelve mice per group.
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Figure 2 Mean xenon clearance Tl/2 at intervals between
10min and 5 days after illumination. 2mg TPPS i.v. per mouse.
Light treatment 24h later. 12 mice per group.
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Figure 3 Mean xenon clearance T1/2 on either (0) day 1 or
(0) day 5 following a range of light doses. 2mg TPPS i.v. per
mouse. Light treatment 24h later. 12 mice per group.
values not significantly different from controls. At doses
higher than this there was a steep rise in the average T1/2
values and at light doses above 151 Jcm-2 there was no
decrease in values between day 1 and day 5.
iii) Relationship between functional vascular impairment and
necrosis in individual mice At the earliest intervals after
PDT (Omin and 1 day), mean T1/2 values for the mice
which underwent tail necrosis following 141 Jcm-2 were
similar to the mean value for those mice whose tails
recovered (Figure 4). However at later intervals, the necrosed
group had higher T1/2 values. Using the Mann-Whitney
test, the differences between the necrosed and recovered
groups were found to be significant on day 2 (P<0.02), day
3 (P<0.01) and day 4 (P<0.01). The T1/2 began to decrease
after day 1 in the recovered group and after day 3 in the
necrosed group, indicating that the former began to recover
earlier. The values for the T1/2 obtained prior to PDT did
not show any significant difference between those mice
which subsequently underwent tail necrosis and those which
did not.
Discussion
We have demonstrated a light-dose related impairment in
Time after light treatment (h)
Figure 4 Mean xenon clearance T1/2 at intervals between
10min and 5 days after illumination for mice which subsequently
underwent tail necrosis (0) and for those in which the tail
recovered (0). 2mg TPPS i.v. per mouse. Light treatment 24h
later with 141 J cm 2.
blood flow in mouse tails one day following PDT, with a
hydrophilic sensitizer. These results are in agreement with
those from previous studies on vascular function in normal
tissues using a lipophilic sensitizer, e.g., Selman et al. (1985a)
although it has been suggested that these may have different
sites of photosensitization (Kessel et al., 1987). To our
knowledge the observed recovery in blood flow has not been
described previously. There was an increase in the average
blood flow between days 1 and 5 at light doses less than
151 Jcm-2. The relatively rapid return of blood flow to
normal at moderate light doses (e.g., 129Jcm-2) may
provide the basis for the clinical observation that recurrences
of cutaneous and subcutaneous malignancies in previously
treated areas may be retreated with PDT without producing
skin necrosis (Dougherty, 1981). Above this threshold
however, the blood flow decreases rapidly with increasing
light dose. This approximates to the dose-response curve for
tail necrosis (cf. Figures 1 and 3) and the theshold values
were similar. Recovery in blood flow therefore may be an
important factor in preventing gross tail necrosis. This is
supported by the evidence from individual mice treated with
a dose near the ED50. There was no significant difference
between the necrosed and the recovered animals when the
measurements were made 10min or 24h after the light
component of PDT. The timing and degree of the recovery
of blood flow seemed to determine the risk of necrosis in
individual mice.
A different aspect of vascular function was studied by Lim
et al. (1985). They used the accumulation of i.v. injected
[1251] bovine serum albumin in guinea pig skin following
PDT as a measure of vascular permeability and
vasodilatation. The ifncrease was greatest at the completion
of irradiation with the values returning to control levels by
18h. Our observations suggest that the impairment of blood
flow may be more prolonged but the disparity may be due to
differences in dose or to species differences.
It is interesting to compare the time course of these
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functional vascular changes with the histological findings of
Bown et al. (1986) who measured the extent of necrosis
occurring in the liver of rats following PDT using either
haematoporphyrin derivative or a phthalocyanine and light
from an Argon pumped tunable dye laser. They found that
maximum necrosis was seen at 24h while healing began to
reduce the lesion size 7 days after treatment. The same group
reported on the histological appearances of rat colon up to
one month following PDT with chloro-aluminium
sulphonated phthalocyanine and laser light. Florid
granulation tissue was observed one week after treatment
(Barr et al., 1987). Kaye et al. (1987) found maximal cerebral
necrosis histologically 2 days after therapy and no significant
change over the next 5 days in rats following PDT with
HpD and laser light.
The underlying mechanism of the vascular effects observed
here remains to be established. Direct photodynamic damage
to the vascular endothelial cells may be responsible for
decreasing blood flow but alternative mechanisms, for
example mast cell damage (Bugelski et al., 1981) or damage
to platelets or red blood cells producing thrombosis may
also be important. Similarly, several mechanisms may
contribute to the observed recovery in blood flow such as
new vessel formation, recanalisation of vessels blocked by
thrombus, or decrease in tissue levels of vasoactive substances
released by mast cells. The nature and time course of this
recovery may however be clinically important in determining
normal tissue tolerance if repeated doses of PDT are given.
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